Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCRL7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,793
Award facts
- Contract value 100% obligated
- $24,793.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc. for 60 tablets of JAKAFI 5 MG on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was issued without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499,999,999 ceiling and extends through December 31, 2036.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical regional pharmaceutical supplier for Department of Defense healthcare operations. The company distributes an extensive portfolio of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to military healthcare facilities. This delivery order for JAKAFI, a prescription pharmaceutical, represents one of numerous orders the company has fulfilled through the PPV-G GEN V program, which is part of the broader $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply across the federal military medical system globally.
Quick answers
Who was awarded contract SPE2DR26FCRL7?
SPE2DR26FCRL7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FCRL7 worth?
The government has obligated $24,793 on SPE2DR26FCRL7.
Is contract SPE2DR26FCRL7 an order under another contract?
Yes. SPE2DR26FCRL7 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRL7 competed?
The extent of competition for SPE2DR26FCRL7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award